Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma (Q33428697)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma |
scientific article |
Statements
1 reference
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma (English)
1 reference
Wim J G Oyen
1 reference
Otto C Boerman
1 reference
Peter F A Mulders
1 reference
Constantijn H J Muselaers
1 reference
Marye J Boers-Sonderen
1 reference
Ingrid M E Desar
1 reference
Alexander B Stillebroer
1 reference
Sasja F Mulder
1 reference
Carla M L van Herpen
1 reference
Johan F Langenhuijsen
1 reference
Egbert Oosterwijk
1 reference
16 December 2015
1 reference
1 reference
69
1 reference
767-770
1 reference
Identifiers
1 reference
1 reference